Glenview Capital Management’s Encompass Health EHC Stock Holding History

Glenview Capital Management’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-167,637	Closed	-$21.3M	–	64
2025 Q3	$21.3M	Buy	+167,637	New	+$20M	0.47%	37
2022 Q4	–	Sell	-349,830	Closed	-$15.8M	–	58
2022 Q3	$15.8M	Sell	349,830 -1,377,605	-80%	-$68.9M	0.4%	39
2022 Q2	$77M	Buy	1,727,435 +111,519	+7%	+$5.72M	1.93%	17
2022 Q1	$91.4M	Buy	1,615,916 +680,962	+73%	+$35.6M	1.85%	18
2021 Q4	$48.5M	Buy	934,954 +431,292	+86%	+$22.2M	1.03%	28
2021 Q3	$30.1M	Buy	+503,662	New	+$31.7M	0.55%	43
2017 Q1	–	Sell	-9,138,113	Closed	-$300M	–	54
2016 Q4	$300M	Buy	9,138,113 +125,700	+1%	+$4.08M	2.03%	18
2016 Q3	$291M	Hold	9,012,413	–	–	2.08%	16
2016 Q2	$278M	Hold	9,012,413	–	–	1.97%	16
2016 Q1	$270M	Buy	9,012,413 +440,829	+5%	+$12.2M	1.97%	21
2015 Q4	$237M	Hold	8,571,584	–	–	1.34%	25
2015 Q3	$262M	Buy	8,571,584 +2,930,287	+52%	+$102M	1.3%	28
2015 Q2	$207M	Buy	5,641,297 +3,503,450	+164%	+$125M	0.82%	42
2015 Q1	$75.4M	Buy	+2,137,847	New	+$73.2M	0.34%	70

Other funds holding EHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Glenview Capital Management's EHC Position: Q4 2025 in Review

Glenview Capital Management sold out of Encompass Health (EHC) in Q4 2025, closing a stake of 167,637 shares — an estimated $21.3M sold.

Glenview Capital Management first reported a position in EHC in Q1 2015 and held it in 14 quarters. The position peaked at $300M in Q4 2016. 593 funds tracked by Wall St. Rank hold EHC as of Q4 2025.

Glenview Capital Management reported no remaining Encompass Health position as of Q4 2025 after selling out during the quarter.
Glenview Capital Management sold 167,637 Encompass Health shares in Q4 2025, an estimated $21.3M.
Glenview Capital Management first reported a position in Encompass Health in Q1 2015 and held it in 14 quarters.
Glenview Capital Management's Encompass Health position peaked at $300M in Q4 2016.
593 funds tracked by Wall St. Rank held Encompass Health as of Q4 2025.

Based on Glenview Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.